NeuroMetrix News - NURO

Company Name	Stock Ticker Symbol	Market	Type
NeuroMetrix Inc	NURO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.03	0.68%	4.44	20:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
4.42	4.30	4.64	4.44	4.41

more quote information »

Recent News

Date	Time	Source	Heading
4/19/2024	08:00	GLOBE	NeuroMetrix Announces Steps Taken to Enhance Shareholder..
3/14/2024	09:00	GLOBE	NeuroMetrix Announces Publication of Study Demonstrating..
3/13/2024	09:00	GLOBE	NeuroMetrix announces that over 2000 patients with..
3/06/2024	17:23	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/06/2024	17:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/06/2024	17:20	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/06/2024	17:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	16:12	EDGAR2	Form SC 13D/A - General statement of acquisition of..
3/01/2024	17:07	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/27/2024	16:45	EDGAR2	Form 8-K/A - Current report: [Amend]
2/27/2024	16:00	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2/26/2024	17:41	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2/22/2024	07:15	EDGAR2	Form 8-K - Current report
2/22/2024	07:00	GLOBE	NeuroMetrix Reports Q4 and Full Year 2023 Business..
2/20/2024	14:49	EDGAR2	Form SCHEDULE 13G - Statement of acquisition of beneficial..
2/15/2024	09:00	GLOBE	NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full..
2/13/2024	09:00	GLOBE	NeuroMetrix Announces Review of Strategic Options to Promote..
12/12/2023	09:00	GLOBE	NeuroMetrix Reports Encouraging Results from Pilot Clinical..
12/05/2023	09:00	GLOBE	NeuroMetrix Announces Peer-Reviewed Publication of Phase 2..
11/20/2023	09:33	EDGAR2	Form 8-K - Current report
11/20/2023	09:00	GLOBE	NeuroMetrix Announces One-for-Eight Reverse Stock Split
10/26/2023	16:20	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/26/2023	07:11	EDGAR2	Form 8-K - Current report
10/26/2023	07:00	GLOBE	NeuroMetrix Reports Q3 2023 Business Highlights
10/23/2023	11:13	GLOBE	NeuroMetrix, Inc. Announces Date for Third Quarter 2023..
10/20/2023	14:59	EDGAR2	Form 8-K - Current report
10/02/2023	09:00	GLOBE	NeuroMetrix and the National Fibromyalgia Association to..
9/11/2023	07:59	EDGAR2	Form DEF 14A - Other definitive proxy statements
8/11/2023	17:11	EDGAR2	Form 8-K - Current report
8/04/2023	18:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/04/2023	18:19	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/04/2023	18:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/04/2023	17:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
7/27/2023	16:19	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
7/27/2023	16:03	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/27/2023	07:24	EDGAR2	Form 8-K - Current report
7/27/2023	07:00	GLOBE	NeuroMetrix Reports Q2 2023 Business Highlights
7/20/2023	13:00	GLOBE	NeuroMetrix, Inc. Announces Date for Second Quarter 2023..
7/11/2023	09:00	GLOBE	NeuroMetrix Announces Sales Force Expansion for Quell..
6/28/2023	09:00	GLOBE	Recent Publications Demonstrate Utility of DPNCheck® for..
6/07/2023	09:00	GLOBE	Diabetic Peripheral Neuropathy Screening That Includes..
5/31/2023	09:00	GLOBE	Quell® Demonstrates Encouraging Clinical Trial Results in..
5/03/2023	07:00	GLOBE	NeuroMetrix Reports Q1 2023 Financial Results
4/28/2023	09:21	GLOBE	NeuroMetrix, Inc. Announces Date for First Quarter 2023..